On the forefront of 3D histology | Translucence Biosystems featured in CALIT2’s Interface Magazine

by
Angela Prvulovic
June 7, 2021

The California Institute for Telecommunications and Information Technology at the University of California, Irvine Fall 2019 issue covers transformational tools. The article features the Mesoscale Imaging System™, developed by then Graduate Student in the dual M.D./Ph.D. program at University of California, Irvine, Ricardo Azevedo and Associate Professor, Sunil Gandhi, Ph.D.

The chamber was inspired in part by the dilemma between compromising sample size and image quality. The Mesoscale Imaging System™ challenges the traditional notion that there should be a compromise between maximizing image quality while allowing larger tissue samples. This enables researchers to sample whole samples, such as mouse brains, versus traditional “slicing” of samples. Utilizing tissue clearing techniques and developing a unique chamber add on to the Zeiss light sheet microscope, researchers can expand the scope of imaging, from imaging 2 regions to over a thousand regions, simultaneously with the same effort.

3D histology offers a diverse platform for various scientific fields aiding in biopsy analysis, disease prognosis, developing clinical trials and drug development.

Read the full feature on Translucence Biosystems here.

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

January 31, 2023
Updates

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
by
Translucence Biosystems
November 13, 2022
Research

Translucence Biosystems Presents at SfN 2022

The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.
by
Translucence Biosystems
May 4, 2022

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine.
by
Angela Prvulovic